1-4 of 4
David Maxwell, PhD
Close
Sort by
Journal Articles

Degrasyn (a novel tyrophostin) Impacts BCR-ABL Protein Level and Is Cytotoxic to Chronic Myeloid Leukemia Early Progenitors

Luke F Peterson, PhD, Hanshi Sun, PhD, William Bornmann, PhD, Zhenghong Peng, PhD, David Maxwell, PhD, Nicholas Donato, Moshe Talpaz
Journal: Blood
Blood (2008) 112 (11): 3212.
https://doi.org/10.1182/blood.V112.11.3212.3212
Published: 2008
Journal Articles

A Novel Small-Molecule Approach To Inhibit Jak2 Tyrosine Kinase Signaling.

Vaibhav Kapuria, MS, Geoffrey Bartholomeusz, PhD, Ling-Yuan Kong, PhD, William Bornmann, PhD, Zhenghong Peng, PhD, Ashutosh Pal, PhD, David Maxwell, PhD, Moshe Talpaz, MD, Nicholas Donato, PhD
Journal: Blood
Blood (2007) 110 (11): 1556.
https://doi.org/10.1182/blood.V110.11.1556.1556
Published: 2007
Journal Articles

Degrasyn-Induced Trafficking of BCR-ABL as a Novel Mechanism of Kinase Inactivation.

Nicholas Donato, PhD, Vaibhav Kapuria, MS, Hanshi Sun, PhD, David Maxwell, PhD, Geoffrey Bartholomeusz, PhD, William Bornmann, PhD, Zhenghong Peng, PhD, Ashutosh Pal, PhD, Moshe Talpaz, MD
Journal: Blood
Blood (2007) 110 (11): 1003.
https://doi.org/10.1182/blood.V110.11.1003.1003
Published: 2007
Journal Articles

APCK110, a Novel and Potent Inhibitor of c-Kit, Blocks Phosphorylation of AKT and STAT3, Induces Apoptosis, and Inhibits Proliferation of Acute Myeloid Leukemia (AML) Cells.

Stefan Faderl, MD, William Bornmann, PhD, David Maxwell, PhD, Ashutosh Pal, Zheng-Hong Peng, Aleksandr Shavrin, David Harris, Quin Van, Liu Zhiming, Srdan Verstovsek, MD, PhD, Taghi Manshouri, MS, BS, Alessandra Ferrajoli, MD, Hagop M. Kantarjian, MD, Zeev Estrov, MD
Journal: Blood
Blood (2006) 108 (11): 153.
https://doi.org/10.1182/blood.V108.11.153.153
Published: 2006